253 related articles for article (PubMed ID: 34442037)
1. Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug.
Gheorghiu ML; Bors RG; Gheorghisan-Galateanu AA; Pop AL; Cretoiu D; Varlas VN
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442037
[TBL] [Abstract][Full Text] [Related]
2. Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until Delivery.
Yoshihara A; Noh JY; Inoue K; Watanabe N; Fukushita M; Matsumoto M; Suzuki N; Suzuki A; Kinoshita A; Yoshimura R; Aida A; Imai H; Hiruma S; Sugino K; Ito K
Thyroid; 2023 Mar; 33(3):373-379. PubMed ID: 36680759
[No Abstract] [Full Text] [Related]
3. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
4. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
5. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
[TBL] [Abstract][Full Text] [Related]
6. Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and Their Neonates.
Iwaki H; Ohba K; Okada E; Murakoshi T; Kashiwabara Y; Hayashi C; Matsushita A; Sasaki S; Suda T; Oki Y; Gemma R
Eur Thyroid J; 2021 Jul; 10(5):372-381. PubMed ID: 34540707
[TBL] [Abstract][Full Text] [Related]
7. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
[TBL] [Abstract][Full Text] [Related]
9. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
Momotani N; Noh JY; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
[TBL] [Abstract][Full Text] [Related]
10. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs.
Laurberg P; Andersen SL
Nuklearmedizin; 2015; 54(3):106-11. PubMed ID: 26105719
[TBL] [Abstract][Full Text] [Related]
11. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
13. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Kahaly GJ; Bartalena L; Hegedüs L; Leenhardt L; Poppe K; Pearce SH
Eur Thyroid J; 2018 Aug; 7(4):167-186. PubMed ID: 30283735
[TBL] [Abstract][Full Text] [Related]
14. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
15. Congenital thyrotoxicosis in premature infants.
Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
[TBL] [Abstract][Full Text] [Related]
16. When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves' disease be discontinued?
Park S; Song E; Oh HS; Kim M; Jeon MJ; Kim WG; Kim TY; Shong YK; Kim DM; Kim WB
Endocrine; 2019 Aug; 65(2):348-356. PubMed ID: 31236779
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
[TBL] [Abstract][Full Text] [Related]
19. MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD.
Pearce EN
Endocr Pract; 2019 Jan; 25(1):62-68. PubMed ID: 30289300
[TBL] [Abstract][Full Text] [Related]
20. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
